Altrua HealthShare and Regenexx partnered to offer Altrua members access to Regenexx's regenerative medicine treatments. By Eric Oliver - 4/19/19

UC San Francisco department of orthopedic surgery researcher Annarita Scaramozza, PhD, has made a discovery that could boost recovery from radiation therapy for cancer treatment with 'super hero' stem cells. By Laura Dyrda - 4/19/19

A new study published in Spine compares open and Wiltse minimally invasive transforaminal lumbar interbody fusion outcomes.  By Laura Dyrda - 4/18/19

The interbody fusion cage market is expected to grow through 2025, according to a MarketReserachNest report. By Laura Dyrda - 4/18/19

Penn Engineering researchers recently examined stem cell transformation and found they could have more influence on shaping their environment and determining functionality, according to a Penn Today report. By Laura Dyrda - 4/15/19

Here are five trends on the evolution of spinal biologics and what to expect in the future. By Laura Dyrda - 4/12/19

Research presented at the Society for Minimally Invasive Spine Surgery Annual Forum in 2018 compares static and expandable interbody devices for minimally invasive transforaminal lumbar interbody fusion. By Laura Dyrda - 4/11/19

Spine surgery is shifting away from traditional devices and toward biologics, a material that attracts cells to increase bone formation in spinal fusion procedures, according to Jeffrey Wang, MD, who is the University of California-Los Angeles spine service chief and director of UCLA's spine surgery fellowship. By Rachel Popa - 4/9/19

A new study published in The Spine Journal examines fusion rate for standalone anterior lumbar interbody fusions. By Laura Dyrda - 4/8/19

New York Attorney General Letitia James is suing New York City-based Park Avenue Stem Cell alleging the clinic performed unproven and rogue procedures on patients, the New York Times reports. By Eric Oliver - 4/5/19

A new study published in the Journal of Neurosurgery: Spine examines the role of BMP use during spinal deformity cases. By Laura Dyrda - 4/4/19

The Journal of Neurosurgery published an article outlining "awake spinal fusion" using the endoscopic transforaminal lumbar interbody fusion technique without general anesthesia. By Laura Dyrda - 4/2/19

InVivo Therapeutics reported raising net proceeds of $16.5 million in 2018 and implemented significant cost savings measures last year. By Laura Dyrda - 4/2/19

Bioventus launched Osteoamp Select Fibers for use with its bone graft substitutes for spine, foot, ankle orthopedic and trauma surgeons. By Rachel Popa - 3/27/19

Using the bone morphogenetic protein rhBMP-2 in the disc space for minimally invasive transforaminal lumbar interbody fusion led to a 97.9 percent fusion rate, according to a study in Clinical Spine Surgery. By Shayna Korol - 3/27/19

The global spinal biologics market is projected to grow at a 3.6 percent compound annual growth rate to reach $2.55 billion by 2024, according to a Market Study Report. By Shayna Korol - 3/26/19

The global spinal fusion market is expected to exceed $1.2 billion by 2027, growing at a 5.4 percent compound annual growth rate, according to a Future Market Insights report. By Laura Dyrda - 3/25/19

Here are 13 key players in the global non-metal orthopedic biomaterial market, according to a Markets N Research report. By Shayna Korol - 3/21/19

AlloSource enrolled the first patient in a study of its ProChondrix CR for articular cartilage defect repair. By Shayna Korol - 3/21/19

The FDA cleared Atreon Orthopedics' Rotium Bioresorbable Wick for healing rotator cuff injuries. By Eric Oliver - 3/19/19